Last week the Drug Enforcement Administration (DEA) issued a bad interim hemp rule. I wrote that it was dangerous because I viewed it as making most hemp processing activities illegal if, at any point in processing hemp, the level of delta-9 THC increases beyond 0.3%– even if the hemp was remediated before it left the
When the 2018 Farm Bill was inked, one of the biggest perceived wins was a provision prohibiting states from interfering with interstate transport or shipment of hemp. It turns out that this protection was for a long time meaningless. Many hemp transporters today face just as much risk when transporting hemp as they did before
On Friday, the Drug Enforcement Administration (“DEA”) released an Interim Final Rule (the “Rule”) that, as we discussed, threatens the hemp industry by treating partially processed hemp extract not intended for consumption (also known as “intermediary hemp”) as a Schedule I controlled substance. This is hugely problematic because intermediary hemp is an essential and necessary
The Drug Enforcement Administration (DEA) issued an interim final rule on hemp (“DEA hemp rule” or “rule”) on August 20, 2020. As per the DEA’s own executive summary, the rule “merely conforms DEA’s regulations to the statutory amendments to the [Controlled Substances Act (CSA)] that have already taken effect, and it does not add additional
For the past eighteen months, hemp stakeholders have been begging the federal government to regulate the hemp-derived cannabidiol (“Hemp CBD”) industry. As of date, the Food and Drug Administration (the “FDA”) has received over 4,000 comments from shareholders on the safety, manufacturing, product quality, marketing, labeling, and sale of Hemp CBD products. There is no doubt that a
La Ley Agrícola de 2018, al excluir el cáñamo de la Ley de Sustancias Controladas, no afectó ni modificó la Ley Federal de Alimentos, Medicamentos y Cosméticos («FDCA») ni la capacidad de la Administración de Alimentos y Medicamentos («FDA») para promulgar reglamentos y directrices relacionados con el cáñamo en virtud de dicha ley. La FDA regula una amplia variedad de productos médicos y de consumo que se venden en
Esta es la segunda entrada de una serie de dos partes. La primera está disponible aquí. La semana pasada, la Administración de Alimentos y Medicamentos (FDA) presentó a la Casa Blanca una política de aplicación de la normativa sobre el CBD. Aún no disponemos del texto de dicho documento, pero prevemos que tendrá un impacto significativo en el CBD derivado del cáñamo (Hemp
La Ley de Mejora de la Agricultura de 2018 (Farm Bill de 2018) legalizó el cáñamo al excluir este cultivo y sus derivados de la definición de marihuana recogida en la Ley de Sustancias Controladas (CSA) y al establecer un marco normativo detallado para su cultivo. La Farm Bill de 2018 otorga al Departamento de Agricultura de los Estados Unidos (USDA) la competencia reguladora sobre el cáñamo
Esta es la primera entrada de una serie de dos partes. La semana pasada, la Administración de Alimentos y Medicamentos (FDA) presentó a la Casa Blanca una política de aplicación de la normativa sobre el CBD. Aún no disponemos del texto de dicho documento, pero prevemos que tendrá un impacto significativo en los productos de CBD derivados del cáñamo (CBD de cáñamo). En previsión de
On July 22, 2020, Clint Eastwood filed two separate lawsuits in federal court in Los Angeles against three CBD manufacturers and marketing companies that posted fabricated online articles falsely claiming that Eastwood endorsed CBD products, as well as ten online CBD retailers that allegedly manipulated search results to make it appear that he had endorsed
